Skip to main content
Equibles

BlackRock, Inc.

Position in BIAF — bioAffinity Technologies, Inc.

CIK 2012383 New York, NY
Back to BIAF Full portfolio

Position in BIAF

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$80,206
New position
Shares Held
6,585
first reported quarter
Ownership
1.22%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 20 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

BlackRock, Inc. holds $59,796,815,474 across 40 Diagnostics & Research names. BIAF ranks #36 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 30,919,632 $15,501,866,689
2 DHR
Danaher Corp /De/
 55,084,630 $10,492,520,314
3 IDXX
Idexx Laboratories Inc /De
 8,170,178 $4,301,108,497
4 A
Agilent Technologies, Inc.
 25,599,001 $3,400,315,293
5 ILMN
Illumina, Inc.
 19,191,398 $3,374,423,500
6 WAT
Waters Corp /De/
 8,484,939 $3,182,191,513
7 NTRA
Natera, Inc.
 10,914,608 $2,962,770,335
8 IQV
Iqvia Holdings Inc.
 14,549,693 $2,811,291,673

All Filings in BIAF

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $80,206 98,777